US$ 29.63
glp 1 agonists and inflammation Frontiers Cardiovascular Effects of Glucagon-Like Peptide-1
Description
In landmark trials such as LEADER and SUSTAIN-6, liraglutide significantly lowered the risk of cardiovascular death, non-fatal myocardial infarction, and stroke by 13% compared to placebo (Marso et al., 2016a)
It is important to note that the efficacy of hormonal contraception, when used orally, decreases because of tirzepatide use

Potential sleep disturbances and bone pain in some individuals
But some researchers titrate too slowly, sitting at sub-therapeutic doses for months

Wang Y, Perfetti R, Greig NH, Holloway HW, DeOre KA, Montrose-Rafizadeh C, et al
